Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|October 22, 2011
Looking to the future: biomarkers in the management of pancreatic adenocarcinomaJennifer L Spratlin, Karen E Mulder
Cancers|November 28, 2013
Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment DecisionsJennifer L Spratlin, John R Mackey
Future Oncology (London, England)|July 14, 2010
Ramucirumab (IMC-1121B): a novel attack on angiogenesisJennifer L Spratlin, Karen E Mulder, John R Mackey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Clinical applications of metabolomics in oncology: a reviewJennifer L Spratlin, Natalie J Serkova, S Gail Eckhardt
Current Opinion in Molecular Therapeutics|November 29, 2007
NMR-based metabolomics: translational application and treatment of cancerNatalie J Serkova, Jennifer L Spratlin, S Gail Eckhardt
World Journal of Clinical Oncology|May 26, 2011
Targeting metastatic upper gastrointestinal adenocarcinomasJennifer L Spratlin, Quincy Chu, Sheryl Koski, et al.
Clinical Colorectal Cancer|March 18, 2014
CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancerJonathan M Loree, Karen E Mulder, Sunita Ghosh, et al.
Journal of Gastrointestinal Cancer|January 11, 2014
Retrospective comparison of CAPOX and FOLFOX dose intensity, toxicity, and clinical outcomes in the treatment of metastatic colon cancerJonathan M Loree, Karen E Mulder, Sunita Ghosh, et al.
Clinical Colorectal Cancer|May 27, 2008
Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancerJennifer L Spratlin, David Hui, John Hanson, et al.
American Journal of Clinical Oncology|April 4, 2017
Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern AlbertaChristina A Kim, Quincy S C Chu, Konrad Fassbender, et al.
Pageof 3